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Introduction: Diabetes is one of the most common endocrine disorders characterized by hyperglycemia due to
defects in insulin secretion, insulin function, or both. Causing dysfunction in the body general metabolism,
diabetes-induced chronic hyperglycemia leads to alterations in those endocrine glands involved in regulating the
body metabolism. In this line, the present study has been conducted to investigate the effects of type 1 and type 2
diabetes on the structural changes and hormonal output of the adrenal cortex in male Wistar rat.
Methods: Eighteen male Wistar rats were divided into three groups including control, experimental type 1 diabetes
(subcutaneous injection of 135 mg/kg alloxan) and experimental type 2 diabetes (8 weeks treatment with drinking
water containing 10% fructose). Two months after the induction of both types of diabetes, the level of blood
biochemical factors (glucose, insulin, cortisol, triglycerides, cholesterol, LDL, and HDL) were measured. Structural
changes of the adrenal cortex were then evaluated, using stereological techniques.
Results: Serum biochemical analysis showed significant difference in the levels of glucose, triglycerides, insulin and
cortisol in experimental groups, compared to the control. The results of structural alterations were also indicative of
increase in adrenal cortex volume in both types of diabetes.
Conclusion: Probably through increasing HPA axis activity, type1 diabetes-induced hyperglycemia leads to adrenal
hypertrophy and increase the hormonal output of adrenal gland.
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Diabetes is characterized by chronic hyperglycemia and
impaired metabolism of carbohydrates, fats and proteins.
The disease is caused by defects in insulin secretion,
insulin function, or both. High blood glucose, as the main
cause of short-term and late complications of diabetes,
leaves serious adverse effects on all body systems including
the endocrine system [1]. Through changing the hormonal
output of endocrine glands, diabetes contributes to the
development of secondary metabolic disorders [2]. On the* Correspondence: behnam@ferdowsi.um.ac.ir
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distribution, and reproduction in any mediumother hand, neuropathy as the most common neurological
complication of diabetes deteriorates the disease condition
via affecting the endocrine system, in addition to peripheral
and autonomic nervous systems [3]. In patients with
diabetes, autonomic nervous system imbalance leads to
increased activity of the hypothalamic-pituitary-adrenal
(HPA) axis, and consequently hypercortisolism and
adrenocortical growth. These alterations are probably due
to reduced relative feedback sensitivity to glucocorticoids
in different parts of the axis, changes in 11- beta hydroxys-
teroid dehydrogenase (11B-HSD) enzyme activity, and
increased expression of corticotropin-releasing hormone in
hypothalamus [4]. In this regard, it has been shown that
there is an increase in cortisol secretion and adrenocorticaled Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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sympathetic neuropathy, compared with type 1 diabetics
with sympathetic neuropathy [5]. Thus, it seems that the
degree of HPA axis dysfunction in diabetic patients is
associated with the damage of neuronal pathway of the
HPA axis and weakening response of glucocorticoids
negative feedback [6]. On this basis, changing level of
hormones such as insulin and glucocorticoids leads to
increased fatty acid release from adipocytes, increased
lipoprotein synthesis in liver cells and subsequent
occurrence of fatty liver and finally resulting in impaired
intracellular insulin signaling and insulin resistance [7].
Thus, changing level of insulin and glucocorticoids, as
well as decreased adipocytes sensitivity to insulin are
probably the reasons behind elevated levels of blood lipid
[7,8]. In addition, via inducing increased expression of
some genes in target tissues, inhibition of beta-oxidation
of lipids in mitochondria, and increased activity of
lipogenic enzymes, glucocorticoids can augment the
level of blood fats; alterations that are inhibited by
adrenalectomy [2,9]. Insulin inhibits the insulin-sensitive
lipase in adipose tissue while in the absence of insulin and
glucocorticoids stimulation, increased activity of this
enzyme may lead to elevated plasma fatty acids [9]. In the
present study, the effects of hyperglycemia, induced by
experimental type 1 and type 2 diabetes on the structural
changes of the adrenal cortex, the levels of blood
biochemical factors, as well as cortisol and insulin in
male Wistar rat have been studied.
Materials and methods
In this study, 18 male Wistar rats, two months of age,
were used which were kept, based on Local Animal Ethic
Committee protocols, under the standard conditions
at 20 ± 2°C temperature and 12:12 light–dark hours
with free access to water and standard food. Rats
were randomly divided into 3 groups (n = 6) including
control, experimental type 1 and type 2 diabetes. For
the induction of type 2 diabetes and insulin resistance,
animals were fed with drinking water containing
10% fructose (Merk, Germany) for two months (i.e. until
4 months of age) [10,11]. During this period, control
and type 1 diabetic group were fed with standard food
and water.
To ensure the induction of type 2 diabetes, rats were
given glucose tolerance test, and fasting insulin resistance
index (FIRI) were compared between control and type 2
diabetic groups. FIRI was calculated via blood sampling
from ocular sinus and measurements of fasting insulin
and glucose levels. To keep the stable state of insulin
resistance, fructose treatment was continued during the
experimental period (the next eight weeks). Animals’
blood glucose changes were regularly measured during
the experiment.Glucose tolerance test
At the end of the eighth week of fructose treatment and
after 12 hours fasting, in addition to evaluating the body
weight, fasting blood glucose was measured using a
glucometer. Then, 40% glucose solution with the concen-
tration of two grams per kilogram of body weight was
intraperitoneally injected to rats, and blood glucose level
was evaluated at 30, 60 and 120 minutes after glucose
injection.
FIRI calculation
Fasting insulin resistance index is a criterion to determine
the induction of type 2 diabetes and can be obtained
through the following formula [12]:
FIRI ¼ Fasting insulin
mIU
ml
  Fastingglucose mgdl
 
25
Type 1 diabetes was induced by a single subcutaneous in-
jection of 135 mg/kg body weight alloxan (Merk, Germany)
to four-month-old rats. Three days after the injection,
blood fasting glucose was measured to confirm the
induction of type 1 diabetes.
At the end of the experimental period (about six
months of age), blood samples were collected from
all the study groups and serum biochemical factors
(glucose, triglycerides, cholesterol, cholesterol-LDL
and cholesterol-HDL), as well as insulin and cortisol
were measured.
Preparation and selection of tissue samples
Cavalier technique
After perfusion, removal of the adrenal gland, and
additional fixation, one of the adrenal glands of each
animal was randomly selected for tissue processing. The
paraffin blocks were then serially sectioned at 7 microns
thick. Initial sections were excluded, and adrenal
sections were serially selected 3 per each 30 sections;
since sampling was initiated by a number between 1 and
30, e.g. 15, the first series included sections number
15-17, second series 45-47 and third series 75-77 and
so on. The aim of this approach was to possess all parts
of the adrenal gland in the total samples of each group.
After Hematoxylin-Eosin staining, each section was
photographed by a digital camera (Olympus Dp71). To
provide a complete image of the adrenal gland, the first
section in each series of sections were photographed
by 2x objective lens. The prepared images were then
used for determining the adrenal gland volume, using
Cavalieri's principle.
Cavalieri's principle is widely used to estimate the
reference volume in stereological studies, especially
biomedical evaluations. In this technique, the volume of
the considered structure can be measured using a
Elahi-Moghaddam et al. Journal of Diabetes & Metabolic Disorders 2013, 12:9 Page 3 of 6
http://www.jdmdonline.com/content/12/1/9series of random sections with equal distances from
one another [13].
Various stages of this procedure are summarized as
follows;
The sample (adrenal gland in this study) was sectioned
as parallel systematic sections with equal distance (d).
Sectioning was initiated randomly. A transparency paper
with a number of uniform points with equal distance
(Figure 1) was then placed on sections, and the number
of points on the considered cross-section (adrenal cortex)
was counted; thus, the total surface area of the adrenal
gland (ΣA) on all sections was calculated, and total
volume of the adrenal cortex was estimated through
the following formula:
V Adrenal glandð Þ ¼ d 
X
A
V = total volume of the considered object (mm3)
d = distance between sections (mm)
ΣA = total surface area of the adrenal gland which is




p a pð Þ
Σ p = number of points counted on the whole surface
areas of the sample
a (p) = area associated with each point (p) (mm2).




To determine the significant difference between different
groups, one-way analysis of variance (ANOVA) was used in
SPSS15 statistical software. Significant differences between
the two groups were calculated using student t-test analysis
(P <0.05 was considered statistically significant). Figures
and tables were also drawn by Excel software.Figure 1 In Cavalieri's principle, the number of points on the
considered surface area is counted.Results
The results of glucose tolerance test showed that fasting
blood glucose was significantly different at 30 min and 2 h
after glucose injection between control and type 2 diabetic
groups. FIRI also revealed a significant increase in type 2
diabetic group compared with control (Figure 2). In the
control and experimental groups, the level of blood glucose
was measured at the beginning (two months of age), after
induction of type 1 and type 2 diabetes (four months of
age) and the end of the study (six months of age) (Figure 3).
Changes in levels of other blood biochemical factors
(Table 1), as well as cortisol (Figure 4) were also evaluated.
The results achieved from the measurement of adrenal
cortex volume displayed a remarkable increase in type 1
and type 2 diabetic groups in comparison with control
(Figure 5).
Discussion
The results of this study showed the induction of type 2
diabetes and insulin resistance following 8 weeks treatment
with fructose. The significant increases in FIRI and glucose
are well indicative of this finding (Figure 2 and 3). In type 1
diabetic group, increase in blood glucose, appetite,
urination, thirst during experimental period indicate
the induction of type I diabetes.
The results in the measurement of adrenal cortex vol-
ume, using Cavalieri's principle demonstrated a remark-
able increase (p < 0.05) in the volume of adrenal cortex
in diabetic, compared with control group; however, the
increase was more significant in type 2 than type 1
diabetes (Figure 5). Such an increment in the adrenal
cortex volume in diabetic groups is in consistence with
the results of previous studies [14-16]. Hypertrophy and
increased adrenal cortex volume can cause increased
secretion of adrenal hormones, including cortisol. In this
regard, measurement of serum cortisol levels showed






















Figure 2 Comparison of FIRI between control and type 2
diabetic animals. *p <0.05, **p <0.01 control group compared with
type 2 diabetes. Sample size: 6 male adult rats. Statistical analysis:





















Figure 3 Changes in serum glucose level in all the study groups during the experimental period. *p <0.05, **p <, 0.01, ***p <0.001 control
group compared with diabetic groups. Sample size: 6 male adult rats. Statistical analysis: ANOVA and student t-test. Type of study: experimental.
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(Table 1). In this line, assessment of urinary metabolites of
cortisol has shown decreased level of these metabolites in
the urine of patients with type 1 diabetes; such a decrease is
probably due to the impairment of metabolic pathways in
hyperglycemic condition, such as 11-beta-HSD pathway,
which converts cortisol to its inactive metabolite (cortisone)
[17]. On the other hand, circadian measurement of cortisol
and ACTH levels in 170 patients with type 2 diabetes
revealed significantly increased in urinary secretion of
cortisol as well as HPA axis activity [18]. These findings
indicate that under hyperglycemic condition, especially
type 2 diabetes, the HPA axis activity and consequently
hormonal output of the adrenal cortex is affected. This
may lead to the incidence of secondary dysfunction in
the activity of other endocrine glands and subsequentlyTable 1 The mean glucose, cortisol, insulin, triglyceride,
cholesterol, cholesterol LDL, and cholesterol HDL in
control and experimental groups at the end of study
Control Type 1diabetes Type 2 diabetes
Serum Glucose
Level (mg/dl)
95.5 ± 10.27 330 ± 82.55*** 177.5 ± 32.6*
Cortisol (nmol/l 36.2 ± 5.88 31.74 ± 11.6 64.8 ± 7.19 **
Insulin (miu/ml) 1.07 ± 0.11 0.97 ± 0.08 1.52 ± 0.17*
Triglyceride (mg/dl) 50.75 ± 4.09 62 ± 10.64* 68.25 ± 16.02
Cholesterol (mg/dl) 61.25 ± 2.29 69.5 ± 4.15 61. 25 ± 1.25
LDL (mg/dl) 36.25 ± 1.8 30.7 ± 3.61 35 ± 1.82
HDL (mg/dl) 16.33 ± 1.2 15.5 ± 1.41 15.33 ± 0.49
*p < 0.05 **p < 0.01 comparison (Mean ± SEM) with control group.
Sample size: 6 male rats.
Statistical methods: ANOVA and student t-test.
Type of study: Experimental.exacerbation and complication of disease if no control
of blood glucose is achieved [4].
Although in physiological condition, HPA axis activity
is influenced by negative feedback of glucocorticoids
[19], chronic glucocorticoids increase reduces the sensi-
tivity of this axis to feedback effects of these hormones.
Such a reduced sensitivity may partly responsible for the
functional impairments and increased activity of HPA
axis in hyperglycemic conditions [19,20]. It is apparently
that increase in ACTH levels contributes to strong
stimulation of adrenal cortex, hypertrophy and elevated
hormonal output [21]. Impaired lipid metabolism and
insulin resistance may also be other possible causes of















Figure 4 Comparison of cortisol levels between control and
diabetic groups. *p <0.05, **p <0.01 diabetic groups compared
with control. Sample size: 6 male adult rats. Statistical analysis:
















Figure 5 Evaluation of the adrenal cortex volume (mm3) in
type 1 and type 2 diabetic rats compared with control. *p
<0.05, **p <0.01 diabetic groups compared with control. Sample
size: 6 male adult rats. Statistical analysis: ANOVA and student t-test.
Type of study: experimental.
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ment of blood biochemical factors show significantly high
serum triglyceride levels in diabetic rats (Table 1). These
findings strongly emphasize the interaction between the
two metabolic hormones, cortisol and insulin [2,21]. There-
fore, this is not unexpected that dysfunction in one causes
dysfunction in another. Similar to the results obtained from
the present study (Table 1), previous reports showed that
type 1 and type 2 diabetes-induced hyperglycemia augment
the levels of cholesterol, triglycerides, LDL and VLDL,
and diminishes the level of HDL [23-26]. Although such
significant and adverse changes in blood lipids and
lipoproteins can be ascribed to alterations in the serum
level of hormones such as insulin and cortisol, the
possibility of other reasons such as liver dysfunction
[27] and subsequent alteration in liver enzymes level [28]
cannot be ignored.
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